Bhartiya Agrow Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 17-12-2024
- Paid Up Capital ₹ 3.29 M
as on 17-12-2024
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 11.91%
(FY 2020)
- Profit 41.88%
(FY 2020)
- Ebitda 49.24%
(FY 2020)
- Net Worth 3.69%
(FY 2020)
- Total Assets -3.69%
(FY 2020)
About Bhartiya Agrow Pharma
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.29 M, as per Ministry of Corporate Affairs (MCA) records.
Sanchit Agarwal, Sushil Agarwal, and Sanjay Agarwal serve as directors at the Company.
- CIN/LLPIN
U24231UP1996PTC019954
- Company No.
019954
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 May 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Bhartiya Agrow Pharma Private Limited offer?
Bhartiya Agrow Pharma Private Limited offers a wide range of products and services, including Hand Sanitizers & Personal Hygiene, Toothpastes, Common Disease Medicines, Herbal Cough Syrup, Ayurvedic Pain Relief Oil, Muscle Pain Oil, Hair Oil, Cool Hair Oil, Pain Killers, Pain Relief Tablet.
Who are the key members and board of directors at Bhartiya Agrow Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanchit Agarwal  | Director | 19-Jul-2016 | Current |
| Sushil Agarwal | Director | 14-May-1996 | Current |
| Sanjay Agarwal | Director | 14-May-1996 | Current |
Financial Performance of Bhartiya Agrow Pharma.
Bhartiya Agrow Pharma Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 11.91% increase. The company also saw a substantial improvement in profitability, with a 41.88% increase in profit. The company's net worth moved up by a moderate rise of 3.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhartiya Agrow Pharma?
In 2020, Bhartiya Agrow Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Agrow Healthcare Private LimitedActive 4 years 7 monthsSanchit Agarwal and Sanjay Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bhartiya Agrow Pharma?
Unlock and access historical data on people associated with Bhartiya Agrow Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhartiya Agrow Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhartiya Agrow Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
